Immunic (IMUX) Return on Capital Employed (2014 - 2026)
Immunic (IMUX) reported Return on Capital Employed of 159.98% for Q1 2026, up 182053.0% on a YoY basis from N/an in Q1 2025, and up 97.27% sequentially from 5865.23% in Q4 2025.
Immunic (IMUX) Return on Capital Employed (2014 - 2026) Analysis & Trends
Immunic (IMUX) has 13 years of Return on Capital Employed data on file, last reported at 159.98% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 182053.0% year-over-year to 159.98%; the trailing twelve-month figure through Mar 2026 stood at 159.98% (up 182053.0% YoY), and the FY2025 full-year result was 5604.13%, down 521822.0% from the prior year.
- Return on Capital Employed improved to 159.98% in Q1 2026, from 5865.23% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 60.66% in Q1 2022 to a low of 5865.23% in Q4 2025.
- A 5-year average of 656.22% and a median of 162.24% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed slumped 554521 bps in 2025 and soared 182053 bps in 2026, its largest moves.
- Tracing IMUX's Return on Capital Employed over 5 years: stood at 107.32% in 2022, then plunged by 157 bps to 276.32% in 2023, then dropped by 16 bps to 320.01% in 2024, then tumbled by 1733 bps to 5865.23% in 2025, then surged by 97 bps to 159.98% in 2026.
- Business Quant data shows IMUX's Return on Capital Employed at 159.98% in Q1 2026, 5865.23% in Q4 2025, and 502.83% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - | -159.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -159.98% |
| Dec 31, 2025 | -5,865.23% |
| Sep 30, 2025 | -502.83% |
| Jun 30, 2025 | -770.66% |
| Mar 31, 2025 | -1,980.51% |
| Dec 31, 2024 | -320.01% |
| Sep 30, 2024 | -183.28% |
| Jun 30, 2024 | -128.91% |
| Mar 31, 2024 | -162.24% |
| Dec 31, 2023 | -276.32% |
| Sep 30, 2023 | -221.66% |
| Jun 30, 2023 | -161.01% |
| Mar 31, 2023 | -122.83% |
| Dec 31, 2022 | -107.32% |
| Sep 30, 2022 | -70.87% |
| Jun 30, 2022 | -61.36% |
| Mar 31, 2022 | -60.66% |
| Dec 31, 2021 | -67.14% |
| Sep 30, 2021 | -61.95% |
| Jun 30, 2021 | -60.57% |